ScreenPoint Insights

Your home for information and innovation in mammography and Breast AI.

Top Posts

 

MASAI RCT: 12% reduction in interval cancer rate using Transpara
New Research

MASAI RCT: 12% reduction in interval cancer rate using Transpara

New book from Joanna Stern highlights personal breast cancer journey
Transpara highlighted in new book I Am Not A Robot by Joanna Stern
News Coverage

New book from Joanna Stern highlights personal breast cancer journey

Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
News Coverage

Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA

All Posts

All TopicsIndustry PerspectiveCompany NewsNews CoverageNew ResearchScreenpoint Event
ScreenPoint Medical: AI-Enhanced Mammography Screening Significantly Improves Breast Cancer Detection and Reduces Radiologist Workload
News Coverage

ScreenPoint Medical: AI-Enhanced Mammography Screening Significantly Improves Breast Cancer Detection and Reduces Radiologist Workload

Only randomized controlled trial of its kind highlights impact of Transpara Breast AI

February 10, 2025
ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities
News Coverage

ScreenPoint Medical Acquires Biomediq A/S to Expand Breast Cancer Risk Assessment Capabilities

Deal brings enhanced capabilities for ScreenPoint’s industry-leading Transpara Breast AI.

January 08, 2025
12

Looking for more? Visit our Evidence page for the latest groundbreaking research in Breast AI. Visit page →

Schedule Demo